SCHWAB CHARLES CORP executive Jonathan M. Craig, MD and Head of Retail Investing, exercised a nonqualified stock option for 21,866 shares of common stock at an exercise price of $46.81 per share on August 14, 2026. The shares received upon exercise were contributed to a revocable trust, after which the same 21,866 shares were sold indirectly by the trust at a weighted average price of $111.0257 per share under a Rule 10b5-1 trading plan adopted on November 11, 2025. The option, granted under the company’s 2013 Stock Incentive Plan, had an original expiration date of March 1, 2029.
SCHWAB CHARLES CORP (SCHW) executive Dennis Howard, MD and Chief Technology, Operations & Data Officer, reported a sale of 2,198 shares of Common Stock on 2026-08-13 at $110.00 per share. The transaction was executed under a Rule 10b5-l trading plan adopted on November 25, 2025, and left him with 6,980 directly held shares.
The Charles Schwab Corporation insider Jonathan Beatty filed a notice to sell 1,000 shares of common stock under Rule 144. The shares relate to an RSU / AWARD from the issuer dated July 1, 2025, with an indicated value of $111,000.00, and are listed on the NYSE. The filing also lists prior common stock sales by Beatty over the past three months on July 2, 6, 7, and 21, 2026, each involving 2,000 shares at reported values ranging from $194,059.00 to $208,411.00.
The Charles Schwab Corporation received a notice that Charles R. Schwab plans to sell up to 90,500 shares of common stock, with an indicated aggregate value of $10,045,500.00, in a transaction dated 08/14/2026 on the NYSE.
The notice also lists multiple sales of common stock by Charles R. Schwab during the prior three months, including transactions ranging from 27,500 to 95,450 shares, with individual aggregate values reaching about $10 million per trade.
Charles R. Schwab, Co-Chairman of Schwab Charles Corp, reported an indirect open-market sale of 46,410 shares of common stock on 2026-08-12 at a weighted average price of $108.176 per share, executed in multiple trades between $108.02 and $108.35. After this transaction, an affiliated limited partnership held 30,021,463 shares, and additional indirect holdings reported include 53,775,791 shares by a trust, 44,025 shares by 188 Corp, and 10,624,797.33 shares by the spouse as trustee.
A Form 144 notice for The Charles Schwab Corporation lists planned sales of its common stock by Charles R. Schwab. The securities section shows entries of 9,977,256.00 and 1,729,335,714 for the common stock. Recent activity over the past three months includes multiple transactions with quantities such as 45,500, 95,450, and 95,250, each paired with multi‑million amounts, indicating sizable planned or recent sales of common shares.
The Charles Schwab Corporation shareholder Dennis Howard filed a Form 144 covering proposed sales of common stock on the NYSE. The filing lists 2,198 common shares with an aggregate value of $241,780.00, related to RSU net shares from the issuer dated 08/01/2026.
It also discloses a prior transaction during the past three months: on 07/28/2026, Dennis Howard sold 28,000 common shares for total proceeds of $2,940,263.00.
The Charles Schwab Corporation issued two tranches of senior debt on August 12, 2026: $1,250,000,000 aggregate principal amount of 5.108% Fixed-to-Floating Rate Senior Notes due 2032 and $1,350,000,000 aggregate principal amount of 5.655% Fixed-to-Floating Rate Senior Notes due 2037. The net proceeds were approximately $2,582 million after underwriting discounts, commissions and estimated expenses. The notes were issued under a Senior Indenture dated November 14, 2025, as supplemented by a Fourth Supplemental Indenture dated August 12, 2026, and were offered under an effective shelf Registration Statement on Form S-3 using an August 10, 2026 prospectus supplement. CSC sold the notes to a syndicate of underwriters led by BofA Securities, Citigroup, Morgan Stanley, TD Securities (USA) and Wells Fargo Securities.
Charles R. Schwab filed a Form 144 notice for potential sales of common stock of The Charles Schwab Corporation, whose shares are listed on the NYSE. The securities information section includes numerical entries of 5,019,706.00 and 1,729,335,714 associated with this planned sale. The filing also lists recent open-market sales of common stock by Charles R. Schwab, including 45,500 shares on 07/24/2026 for $4,628,192.00, 95,450 shares on 07/29/2026 for $10,100,057.00, and 95,250 shares on 08/03/2026 for $10,050,418.00, among other transactions during May through August 2026.
The Charles Schwab Corporation is offering $1.25 billion of 5.108% Fixed‑to‑Floating Rate Senior Notes due August 12, 2032 and $1.35 billion of 5.655% Fixed‑to‑Floating Rate Senior Notes due August 12, 2037. Both series pay a fixed coupon until one year before maturity, then convert to a floating rate based on compounded SOFR plus 0.950% for the 2032 notes and compounded SOFR plus 1.320% for the 2037 notes, with interest paid quarterly in the floating period.
The notes are senior unsecured obligations of CSC, ranking equally with other senior unsecured debt but structurally subordinated to liabilities of subsidiaries. They are not FDIC‑insured, not guaranteed by subsidiaries, and will not be listed on an exchange, so liquidity will depend on dealer markets. CSC may redeem the notes at its option on specified dates, potentially limiting the benefit of higher future rates. Net proceeds of about $2.582 billion are intended for general corporate purposes. Key risks include subordination to subsidiary creditors, limited covenants, call risk, market value sensitivity to interest rates and credit ratings, and benchmark transition and calculation risks related to SOFR.